16 September 2020>: Articles
Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature
Unusual or unexpected effect of treatment
Xavier Carrier E , Sumit Gaur E , Alexander Philipovskiy A*DOI: 10.12659/AJCR.925248
Am J Case Rep 2020; 21:e925248
Table 1. Laboratory values (case report patient).
Labs | Before immune-chemotherapy | On admissionafter the first dose of immune-chemotherapy | Four days later before the discharge for the hospital | Two weeks after the event | Normal range |
---|---|---|---|---|---|
Uric acid | N/A | 17.8 | 2.5–6.2 (mg/dL) | ||
Potassium | 4.4 | 5.5 | 4.1 | 3.8 | 3.5–5.1 (mmol/L) |
Phosphorus | N/A | 5.0 | 3.3 | 3.8 | 2.5–4.5 (mg/dL) |
Calcium | 9.3 | 9.2 | 8.6 | 8.5 | 8.4–10.2 (mg/dL) |
Creatinine | 0.80 | 4.5 | 1.9 | 0.6 | 0.52–1.04 9mg/dL) |
N/A – not available. |